Dynavax Technologies Corporation (DVAX)

Return on equity (ROE)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	-6,389	61,125	110,641	235,965	293,156	325,202	232,963	108,681	76,713	-38,533	-5,702	-61,754	-75,245	-96,534	-134,394	-125,528	-152,600	-155,813	-162,882	-159,613
Total stockholders’ equity	US$ in thousands	622,072	604,916	577,205	563,732	581,013	500,576	422,799	287,484	222,374	67,576	83,380	99,762	58,693	69,284	58,295	11,824	8,290	39,156	10,588	43,159
ROE		-1.03%	10.10%	19.17%	41.86%	50.46%	64.97%	55.10%	37.80%	34.50%	-57.02%	-6.84%	-61.90%	-128.20%	-139.33%	-230.54%	-1,061.64%	-1,840.77%	-397.93%	-1,538.36%	-369.83%

December 31, 2023 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $-6,389K ÷ $622,072K
= -1.03%

The return on equity (ROE) for Dynavax Technologies Corp. has been quite volatile over the past eight quarters, ranging from a low of -1.03% in Q4 2023 to a high of 64.11% in Q3 2022.

The significant fluctuations in ROE could indicate varying levels of profitability and financial performance. The positive ROE values suggest that the company is generating profit with the shareholders' equity invested in the business, while the negative ROE in Q4 2023 indicates a loss relative to equity.

Overall, the trend shows that the company's ROE has generally been on an upward trajectory from Q1 2022 to Q2 2023, reaching its peak at 64.11% in Q3 2022 before decreasing in the most recent quarter.

Further analysis of the company's financial statements and business operations would be needed to understand the drivers behind these changes in ROE and to assess the sustainability of the company's performance in the future.